F.D.A. Panel Recommends Approval Of LDL Chloesterol Lowering Drug Which Mimics Mutations In PCSK9 Gene

Federal Panel Recommends Approving New Cholesterol Drug by Gina Kolata.  The New York Times.  June 9, 2015.